Jones Financial Reduces Stake in VanEck Biotech ETF Amid Market Adjustments Jones Financial Companies has reduced its stake in VanEck Biotech ETF by 4%, now holding 2,617 shares worth $411,000. Other institutional investors have also shown varied activity, with some acquiring new stakes in recent quarters. The ETF's stock price remains stable, trading near its 50-day moving average of $162.42.2